Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pflugers Arch
2008 May 01;4562:413-23. doi: 10.1007/s00424-007-0391-3.
Show Gene links
Show Anatomy links
Molecular basis for genistein-induced inhibition of Kir2.3 currents.
Zhao Z
,
Liu B
,
Zhang G
,
Jia Z
,
Jia Q
,
Geng X
,
Zhang H
.
???displayArticle.abstract???
Inwardly rectifying potassium channels play an important role in the maintenance of membrane potential in neurons and myocardium. Identification of functional regulation mechanisms concerning these channels may lead to the development of specific modulators for these channels. Genistein is an isoflavone with potent inhibitory activity on protein tyrosine kinase. In this study, we have found that among three members of the Kir family (Kir2.3, Kir2.1, and Kir3.4* [a highly active mutant of Kir3.4, Kir3.4-S143T]) we tested, genistein significantly inhibited Kir2.3 currents. Using the two-electrode voltage clamp technique, we have demonstrated that micromole concentrations of genistein concentration-dependently and reversibly inhibited the currents of Kir2.3 channel expressed in Xenopus oocytes with an IC50 of 16.9+/-2.8 microM. Using the whole-cell patch-clamp technique, genistein also inhibited the currents of Kir2.3 channel expressed in HEK293 cells with an IC50 of 19.3+/-3.2 microM. Genistein had little or no effect on Kir2.1 and Kir3.4* currents. The effect of genistein on Kir2.3 currents was not affected by vanadate, a potent protein tyrosine phosphatase inhibitor. Furthermore, the effect of genistein was not mimicked by daidzein, an inactive analogue of genistein, or another potent tyrosine kinase inhibitor, tyrphostin 23. Chimeras between Kir2.3 and Kir2.1 channels were constructed to identify molecular basis that distinguished the effect of genistein on these channels. It was found that the transmembrane domains and the pore region of Kir2.3 channel were important determinant for high sensitivity for genistein inhibition.
Abraham,
Channelopathies of inwardly rectifying potassium channels.
1999, Pubmed
Abraham,
Channelopathies of inwardly rectifying potassium channels.
1999,
Pubmed
Akiyama,
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
1987,
Pubmed
Altavilla,
Cardiovascular effects of the phytoestrogen genistein.
2004,
Pubmed
Altomare,
Direct inhibition of the pacemaker (If) current in rabbit sinoatrial node cells by genistein.
2006,
Pubmed
Belevych,
Genistein inhibits cardiac L-type Ca(2+) channel activity by a tyrosine kinase-independent mechanism.
2002,
Pubmed
Bourgoin,
Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation.
1992,
Pubmed
Chiang,
Genistein inhibits the inward rectifying potassium current in guinea pig ventricular myocytes.
2002,
Pubmed
Chiang,
Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride currents in cardiomyocytes.
1996,
Pubmed
Chuang,
Regulation of IRK3 inward rectifier K+ channel by m1 acetylcholine receptor and intracellular magnesium.
1997,
Pubmed
,
Xenbase
Collins,
A strongly inwardly rectifying K+ channel that is sensitive to ATP.
1996,
Pubmed
,
Xenbase
Collins,
Differential sensitivity of inward rectifier K+ channels to metabolic inhibitors.
2002,
Pubmed
,
Xenbase
Correia,
Molecular characterization of an inward rectifier channel (IKir) found in avian vestibular hair cells: cloning and expression of pKir2.1.
2004,
Pubmed
Coulter,
Identification and molecular localization of a pH-sensing domain for the inward rectifier potassium channel HIR.
1995,
Pubmed
,
Xenbase
Du,
Characteristic interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels by diverse modulators.
2004,
Pubmed
,
Xenbase
Gazit,
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
1989,
Pubmed
Hashimoto,
Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation.
2006,
Pubmed
Henry,
Protein kinase C inhibition of cloned inward rectifier (HRK1/KIR2.3) K+ channels expressed in Xenopus oocytes.
1996,
Pubmed
,
Xenbase
Hwang,
Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics.
2003,
Pubmed
Inanobe,
Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic membrane of excitatory synapses.
2002,
Pubmed
Isomoto,
Inwardly rectifying potassium channels: their molecular heterogeneity and function.
1997,
Pubmed
,
Xenbase
Jin,
A novel high-affinity inhibitor for inward-rectifier K+ channels.
1998,
Pubmed
,
Xenbase
Kubo,
Primary structure and functional expression of a mouse inward rectifier potassium channel.
1993,
Pubmed
,
Xenbase
Kurejová,
Effect of protein tyrosine kinase inhibitors on the current through the Ca(V)3.1 channel.
2006,
Pubmed
Liu,
Direct activation of an inwardly rectifying potassium channel by arachidonic acid.
2001,
Pubmed
Lopes,
Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies.
2002,
Pubmed
,
Xenbase
Okamoto,
Genistein, a soybean isoflavone, inhibits inward rectifier K(+) channels in rat osteoclasts.
2001,
Pubmed
Paillart,
Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor.
1997,
Pubmed
Plaster,
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
2001,
Pubmed
,
Xenbase
Posner,
Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
1994,
Pubmed
Périer,
Primary structure and characterization of a small-conductance inwardly rectifying potassium channel from human hippocampus.
1994,
Pubmed
,
Xenbase
Qu,
Identification of a critical motif responsible for gating of Kir2.3 channel by intracellular protons.
1999,
Pubmed
,
Xenbase
Ruppersberg,
Intracellular regulation of inward rectifier K+ channels.
2000,
Pubmed
Teisseyre,
Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes.
2005,
Pubmed
Vivaudou,
Probing the G-protein regulation of GIRK1 and GIRK4, the two subunits of the KACh channel, using functional homomeric mutants.
1997,
Pubmed
,
Xenbase
Washizuka,
Genistein inhibits slow component delayed-rectifier K currents via a tyrosine kinase-independent pathway.
1998,
Pubmed
Weinreich,
Direct action of genistein on CFTR.
1997,
Pubmed
,
Xenbase
Whaley,
Interactions of genistein and related isoflavones with lipid micelles.
2006,
Pubmed
Yan,
Different intracellular polyamine concentrations underlie the difference in the inward rectifier K(+) currents in atria and ventricles of the guinea-pig heart.
2005,
Pubmed
Zhang,
Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein tyrosine kinase inhibitor genistein.
2000,
Pubmed
Zhang,
Activation of inwardly rectifying K+ channels by distinct PtdIns(4,5)P2 interactions.
1999,
Pubmed
,
Xenbase
Zielonka,
Radical scavenging properties of genistein.
2003,
Pubmed
Łania-Pietrzak,
Metabolic O-demethylation does not alter the influence of isoflavones on the biophysical properties of membranes and MRP1-like protein transport activity.
2005,
Pubmed
